← Back to guidelines
Nephrology39 papers

Neoplasm of renal pelvis

Last edited: 4/14/2026

Overview

Neoplasm of the renal pelvis encompasses various types of tumors, including benign and malignant lesions such as oncocytomas, adenomas, and carcinomas. Diagnosis and management depend on tumor characteristics, patient factors, and clinical context.

Diagnosis

  • Imaging studies (CT, MRI, ultrasound) are essential for initial evaluation 1211.
  • Percutaneous needle biopsy may be considered for indeterminate masses, though practice varies 8.
  • Histological examination following nephrectomy or biopsy confirms specific tumor types (e.g., oncocytoma, adenoma, fibroma) 101213141516171819.
  • Chromosomal analysis can provide additional insights in complex cases 10.
  • Management

  • Surgical Options:
  • - Partial nephrectomy (PN) is preferred for small renal masses to preserve renal function 26. - Laparoscopic and robot-assisted techniques are increasingly utilized 29. - Hand-assisted laparoscopic nephrectomy is another approach for localized masses 9.
  • Non-Surgical Approaches:
  • - Active surveillance and ablation (e.g., radiofrequency ablation) are considered for low-risk tumors 611. - Resident exposure to conservative therapies like ablation and surveillance is limited and needs improvement 5.

    Special Populations

  • Pediatrics: Minimally invasive surgery (MIS) and nephron-sparing surgery (NSS) adoption varies between pediatric urologists and surgeons 3.
  • Elderly: Polypharmacy impacts perioperative outcomes in elderly patients undergoing robotic partial nephrectomy; careful medication management is crucial 1.
  • Comorbidities: Surgical risk stratification is essential, influencing decisions between surgical resection and active surveillance 6.
  • Key Recommendations

  • Prefer Partial Nephrectomy for Small Renal Masses to preserve renal function 26 (Evidence: Strong).
  • Consider Active Surveillance for Low-Risk Tumors based on tumor characteristics and patient factors 6 (Evidence: Moderate).
  • Enhance Resident Training in Conservative Therapies such as ablation and surveillance for better management of small renal masses 5 (Evidence: Expert opinion).
  • Evaluate Perioperative Risk Factors including polypharmacy in elderly patients undergoing robotic surgery 1 (Evidence: Moderate).
  • Adopt Minimally Invasive Techniques for pediatric renal masses, considering subspecialty practice patterns 3 (Evidence: Moderate).
  • References

    1 Nemoto Y, Ishihara H, Nakamura K, Nishimura K, Fukuda H, Yoshida K et al.. Impact of Polypharmacy on Perioperative Outcomes of Robot-assisted Laparoscopic Partial Nephrectomy for Small Renal Masses. In vivo (Athens, Greece) 2025. link 2 Paludo AO, Knijnik P, Brum P, Cachoeira E, Gorgen A, Burttet L et al.. Urology Residents Simulation Training Improves Clinical Outcomes in Laparoscopic Partial Nephrectomy. Journal of surgical education 2021. link 3 Hensley PJ, Saltzman AF, Ziada AM. Surgical management of pediatric renal masses: surgeon subspecialty practice patterns. The Canadian journal of urology 2020. link 4 Rabah F, Ramadhan FA, Chacko AP. Renal mass: is it always worrisome?. Journal of pediatric hematology/oncology 2014. link 5 Elliott VL, Smith PH, Raman JD. Are urology residents adequately exposed to conservative therapies for managing small renal masses?. Journal of endourology 2011. link 6 Mues AC, Landman J. Small renal masses: current concepts regarding the natural history and reflections on the American Urological Association guidelines. Current opinion in urology 2010. link 7 Van der Kwast T, Perez-Ordoñez B. Renal oncocytoma, yet another tumour that does not fit in the dualistic benign/malignant paradigm?. Journal of clinical pathology 2007. link 8 Khan AA, Shergill IS, Quereshi S, Arya M, Vandal MT, Gujral SS. Percutaneous needle biopsy for indeterminate renal masses: a national survey of UK consultant urologists. BMC urology 2007. link 9 Pietrow PK, L'Esperance JO, Auge BK, Terranova S, Sung J, Ekeruo W et al.. Hand-assisted laparoscopic nephrectomy: the transfer of experience to a new academic center. Journal of endourology 2004. link 10 Kostakopoulos A, Chorti M, Protogerou V, Kokkinou S. Solitary neurofibroma of kidney: clinical, histological and chromosomal appearance. International urology and nephrology 2003. link 11 Yohannes P, Pinto P, Rotariu P, Smith AD, Lee BR. Retroperitoneoscopic radiofrequency ablation of a solid renal mass. Journal of endourology 2001. link 12 Suzuki T, Arai T, Mukae K, Takasaki E. Case of renal medullary fibroma. Urology 1992. link90485-f) 13 Vlassopoulos G, Sakkas G, Legaki S, Sofras F, Karagiannis A. Inverted papilloma of the renal pelvis. International urology and nephrology 1992. link 14 Engel U, Horn T, Nielsen OS, Olsen JH. Renal oncocytoma. Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology 1987. link 15 Lafortune M, Breton G. Echographic demonstration of an oncocytoma. Journal of the Canadian Association of Radiologists 1983. link 16 Bokinsky GB. Renal oncocytoma. Urology 1981. link90268-5) 17 Cass AS. Large renal adenoma. The Journal of urology 1980. link55408-7) 18 Pearse HD, Houghton DC. Renal oncocytoma. Urology 1979. link90021-9) 19 Milstoc M. Renal oncocytoma: a rare case of renal adenoma. The Journal of urology 1977. link58222-1)

    Original source

    1. [1]
      Impact of Polypharmacy on Perioperative Outcomes of Robot-assisted Laparoscopic Partial Nephrectomy for Small Renal Masses.Nemoto Y, Ishihara H, Nakamura K, Nishimura K, Fukuda H, Yoshida K et al. In vivo (Athens, Greece) (2025)
    2. [2]
      Urology Residents Simulation Training Improves Clinical Outcomes in Laparoscopic Partial Nephrectomy.Paludo AO, Knijnik P, Brum P, Cachoeira E, Gorgen A, Burttet L et al. Journal of surgical education (2021)
    3. [3]
      Surgical management of pediatric renal masses: surgeon subspecialty practice patterns.Hensley PJ, Saltzman AF, Ziada AM The Canadian journal of urology (2020)
    4. [4]
      Renal mass: is it always worrisome?Rabah F, Ramadhan FA, Chacko AP Journal of pediatric hematology/oncology (2014)
    5. [5]
    6. [6]
    7. [7]
      Renal oncocytoma, yet another tumour that does not fit in the dualistic benign/malignant paradigm?Van der Kwast T, Perez-Ordoñez B Journal of clinical pathology (2007)
    8. [8]
      Percutaneous needle biopsy for indeterminate renal masses: a national survey of UK consultant urologists.Khan AA, Shergill IS, Quereshi S, Arya M, Vandal MT, Gujral SS BMC urology (2007)
    9. [9]
      Hand-assisted laparoscopic nephrectomy: the transfer of experience to a new academic center.Pietrow PK, L'Esperance JO, Auge BK, Terranova S, Sung J, Ekeruo W et al. Journal of endourology (2004)
    10. [10]
      Solitary neurofibroma of kidney: clinical, histological and chromosomal appearance.Kostakopoulos A, Chorti M, Protogerou V, Kokkinou S International urology and nephrology (2003)
    11. [11]
      Retroperitoneoscopic radiofrequency ablation of a solid renal mass.Yohannes P, Pinto P, Rotariu P, Smith AD, Lee BR Journal of endourology (2001)
    12. [12]
      Case of renal medullary fibroma.Suzuki T, Arai T, Mukae K, Takasaki E Urology (1992)
    13. [13]
      Inverted papilloma of the renal pelvis.Vlassopoulos G, Sakkas G, Legaki S, Sofras F, Karagiannis A International urology and nephrology (1992)
    14. [14]
      Renal oncocytoma.Engel U, Horn T, Nielsen OS, Olsen JH Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology (1987)
    15. [15]
      Echographic demonstration of an oncocytoma.Lafortune M, Breton G Journal of the Canadian Association of Radiologists (1983)
    16. [16]
      Renal oncocytoma.Bokinsky GB Urology (1981)
    17. [17]
      Large renal adenoma.Cass AS The Journal of urology (1980)
    18. [18]
      Renal oncocytoma.Pearse HD, Houghton DC Urology (1979)
    19. [19]
      Renal oncocytoma: a rare case of renal adenoma.Milstoc M The Journal of urology (1977)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG